Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-050966
Filing Date
2026-05-01
Accepted
2026-05-01 16:16:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0287961-424b3_enlivex.htm 424B3 133425
2 GRAPHIC ea028692001_img1.jpg GRAPHIC 15610
  Complete submission text file 0001213900-26-050966.txt   156478
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-295215 | Film No.: 26932767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)